Cationic LNP-formulated mRNA expressing Tie2-agonist in the lung endothelium prevents pulmonary vascular leakage

Katrin Radloff(Cleopa (Germany)), Martin Witzenrath(Humboldt-Universität zu Berlin)

Molecular Therapy — Nucleic Acids

October 29, 2023

10.1016/j.omtn.2023.102068

Cited by 13

Related Papers

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19

|Nature|2020|1.4k

A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model

|Cell|2020|387

Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial

|The Lancet Rheumatology|2020|199

Presence of SARS-CoV-2-reactive T cells in COVID-19 patients and healthy donors

|medRxiv|2020|178

Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

|The Lancet Respiratory Medicine|2022|143